Quarterly ResultMay 5, 2026, 04:03 PM
Dentsply Sirona Q1 Net Sales $880M; GAAP EPS ($0.05); Adjusted EPS $0.27
AI Summary
Dentsply Sirona reported Q1 2026 net sales of $880 million, a slight increase of 0.1% year-over-year. The company posted a GAAP net loss per share of ($0.05) and adjusted EPS of $0.27, down 39.0% from the prior year. Despite near-term pressures, Dentsply Sirona launched its AI-enabled diagnostic aid, Smart View-Detect, expanded distribution agreements, and began implementing a new capital allocation strategy. The company reiterated its full-year 2026 outlook for net sales and adjusted EPS.
Key Highlights
- Q1 2026 net sales were $880 million, a 0.1% increase year-over-year.
- Reported GAAP net loss per share was ($0.05), compared to $0.10 in Q1 2025.
- Achieved adjusted EPS of $0.27, a 39.0% decrease from $0.44 in Q1 2025.
- Launched Smart View-Detect, an FDA-cleared and CE-marked AI-enabled diagnostic aid.
- Connected Technology Solutions segment net sales grew 4.4% to $246 million.
- Wellspect Healthcare segment net sales increased 15.0% to $85 million.
- Operating cash flow improved to $40 million in Q1 2026 from $7 million in Q1 2025.
- Reiterated 2026 outlook for net sales of $3.5 billion to $3.6 billion and adjusted EPS of $1.40 to $1.50.